In AML, Immunotherapy Shows Promise to Expand Treatment Toolbox

Most of the research suggests combination therapies might be the best option for many patients who have acute myeloid leukemia (AML).

Related Keywords

,Bristol Myers Squibb ,Vitalii Vodolazskyi Stock ,Acute Myeloid Leukemia ,Immunotherapy ,Hematopoietic Stem Cell ,Relapse ,Tumor Microenvironment ,Immune Microenvironment ,